Significant Ownership of John D. Halpern

Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by John D. Halpern.

Notify me when John D. Halpern files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of John D. Halpern

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ERNA Eterna Therapeutics Inc. Common Stock, par value $0.005 per share 9.6% $1,254,084 +$175,402 5,971,830 +16% John D. Halpern 31 Mar 2025

Schedules 13D/G Reported by John D. Halpern:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.